Table 4.

Clinical profile of patients with PFS of EGFR-TKIs treatment >6 months

Case	Sex	Age (years)	Stage	Smoking	Gene type	EGFR-TKIs PFS (months)	OS (months)
1	Female	59	IV	No	S768I	8.6	67+
2	Male	66	IIIB	No	T790M + 19 delete	6.6	42
3	Male	62	IV	No	20 insertion + 19 delete	8.7	34
4	Female	56	IV	No	T790M + L858R	6.7	66+
5	Male	64	IV	Yes	20 insertion	9.1	35+
6	Female	49	IV	No	S768I + L858R	12.7	54
7	Male	47	IV	Yes	20 insertion + L858R	9.0	36+
8	Male	68	IV	No	T790M + L858R	10.7	55
9	Female	63	IV	No	T790M + G719X	6.0	43+
10	Female	55	IV	No	S768I + 19 delete	8.8	25
11	Male	57	IV	Yes	20 insertion	8.0	46+

Abbreviations: PFS, progression-free survival; EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitor; OS, overall survival.